FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77479
News■ Mixed
Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison.
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A mouse study linking semaglutide to late-life lean mass loss raises a safety narrative for GLP-1 drugs, though animal data is not clinical evidence.
GLP-1 muscle-loss narrative gets another data point
CATALYST TO WATCH
Human trial data on lean mass preservation
MAIN RISK
Animal findings may not translate to humans
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Med Tech Solutions Unifies Stoltenberg Consulting and Avarion Under the MTS Brand2026-10-13 12:00 UTC
Med Tech Solutions Unifies Stoltenberg Consulting and Avarion Under the MTS Brand2026-10-13 12:00 UTC
→CORRELATIONshares Healthcare
NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers2026-10-13 12:01 UTC
NextPlat Opens New Jacksonville Pharmacy Location to Offer High-Value Services for Patients and Local Healthcare Providers2026-10-13 12:01 UTC
→CORRELATIONshares Healthcare
symplr's Compass Survey Finds Nearly Half of Healthcare Operations Remain Manual2026-10-13 12:05 UTC
symplr's Compass Survey Finds Nearly Half of Healthcare Operations Remain Manual2026-10-13 12:05 UTC
→CORRELATIONshares Healthcare
Prosper AI Report Finds $108 Billion Annual Revenue Opportunity for U.S. Specialty Practices2026-10-13 12:05 UTC
Prosper AI Report Finds $108 Billion Annual Revenue Opportunity for U.S. Specialty Practices2026-10-13 12:05 UTC
→CORRELATIONshares Healthcare
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 20262026-10-13 12:05 UTC
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 20262026-10-13 12:05 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.